The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.

Excerpt from NBC News. Original publication ↗

Source: NBC News

At a glance

Topic
World
Country
🇺🇸 US
Publisher language
EN
Added to Allnira